Special Supplement, November 2022

Articles

• 

  Expert clinical framework report: Management of adverse events related to novel therapies for relapsed/refractory multiple myeloma (RRMM)

  Jill Lacey, BSc, BSP, ACPR, Joanne Hewitt, PhD, NP, Jennifer L. Daley-Morris, RPh, BPharm, Judith James, RN, BSc, Jonathan Stevens, BPharm, ACPR, Olivier Blaizel, BPharm

  • PDF (en)
  • PDF (fr)